Clinical Trial Update: Comparing Immune System Suppression to Medication for Unexplained Heart Function and Irregular Heartbeat [Phase 4]

View source ↗

Summary

Phase 4 trial update notes ongoing enrollment to compare immunosuppressive therapy against standard heart medications for unexplained heart dysfunction with ven…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmogenic Inflammatory Cardiomyopathy
• Non-ischemic Cardiomyopathy
• Ventricular Arrhythmia

Drugs mentioned

• Immunosuppressants (unspecified) (immunosuppressive agents)
• Standard heart failure/arrhythmia medications (unspecified) (standard heart failure/arrhythmia drugs)

Snippet

Sponsor: Roderick Tung | Conditions: Ventricular Arrythmia, Non-ischemic Cardiomyopathy | Phase 4 | Status: ENROLLING_BY_INVITATION